☆ 4.7 Review

Mechanism of COVID-19 Causing ARDS: Exploring the Possibility of Preventing and Treating SARS-CoV-2

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2022)

Related references

Note: Only part of the references are listed.

Article Biochemistry & Molecular Biology

T cell apoptosis characterizes severe Covid-19 disease

Sonia Andre et al.

Summary: By comparing COVID-19 patients with healthy donors, the study found a strong correlation between T cell apoptosis and lymphopenia in severe cases. The plasma levels of soluble FasL (sFasL) and T cell surface expression of Fas/CD95 were positively correlated with T cell death and CD4 T cell counts. The study also identified modulations in the Bcl-2 family and demonstrated the potential of a pan-caspase inhibitor, Q-VD, to prevent T cell apoptosis and enhance Th1 transcripts.

CELL DEATH AND DIFFERENTIATION (2022)

Add to Collection

Article Cell Biology

SARS-CoV-2 Nsp13 encodes for an HLA-E-stabilizing peptide that abrogates inhibition of NKG2A-expressing NK cells

Quirin Hammer et al.

Summary: A viral peptide encoded by the Non-structural protein 13 of SARS-CoV-2 prevents the binding of HLA-E to the inhibitory receptor NKG2A, leading to the activation of NK cells and their ability to limit viral replication. This finding provides insights into the immune response of NK cells against SARS-CoV-2 and its mechanisms.

CELL REPORTS (2022)

Add to Collection

Article Medicine, General & Internal

Perspective: Vitamin D deficiency and COVID-19 severity - plausibly linked by latitude, ethnicity, impacts on cytokines, ACE2 and thrombosis

J. M. Rhodes et al.

Summary: There is substantial evidence supporting a link between vitamin D deficiency and COVID-19 severity, although the evidence is indirect. Community-based placebo-controlled trials of vitamin D supplementation may be challenging, but further evidence may come from large cohort studies with prescribing data or serum 25(OH) vitamin D level assays. In the meantime, vitamin D supplementation is strongly recommended for individuals at risk of deficiency.

JOURNAL OF INTERNAL MEDICINE (2021)

Add to Collection

Review Immunology

T-cell responses and therapies against SARS-CoV-2 infection

Salman M. Toor et al.

Summary: COVID-19 is potentially an immune-related disease, where T cells play a crucial role with both pro- and anti-functions. Understanding the role of T cells in immune responses is essential for better management of COVID-19.

IMMUNOLOGY (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Functional SARS-CoV-2-Specific Immune Memory Persists after Mild COVID-19

Lauren B. Rodda et al.

Summary: The study found that individuals recovered from mild COVID-19 develop sustained SARS-CoV-2-specific immunological memory for at least 3 months, including immunoglobulin antibodies, neutralizing plasma, and memory B and T cells. These memory lymphocytes exhibit potent antiviral function, aiding in immune defense.

CELL (2021)

Add to Collection

Review Biochemistry & Molecular Biology

Adaptive immunity to SARS-CoV-2 and COVID-19

Alessandro Sette et al.

Summary: The adaptive immune system, consisting of B cells, CD4(+) T cells, and CD8(+) T cells, plays varying roles in different viral infections and vaccines. Studies are showing that CD4(+) T cells, CD8(+) T cells, and neutralizing antibodies all play a part in controlling SARS-CoV-2 in COVID-19 cases, emphasizing the importance of understanding adaptive immunity in combating the disease.

CELL (2021)

Add to Collection

Article Infectious Diseases

Could SARS-CoV-2-induced lung injury be attenuated by vitamin D?

Dongqiong Xiao et al.

Summary: This article discusses the transmission of novel coronavirus from humans to humans, the role of ACE2 in the pathogenesis of ARDS and acute lung injury, and the potential of vitamin D in modulating ACE2 to alleviate the symptoms induced by the virus.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2021)

Add to Collection

Review Biochemistry & Molecular Biology

The Immunopathological and Histological Landscape of COVID-19-Mediated Lung Injury

Giovanni Zarrilli et al.

Summary: The histopathologic alterations in COVID-19 patients primarily occur in the lungs and blood vessels, with the highest clinical impact. However, many of the collected morphological data so far are nonspecific, erratic, and possibly associated with other co-existing factors.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Add to Collection

Review Medicine, General & Internal

JAK-STAT Pathway Inhibition and their Implications in COVID-19 Therapy

Sairaj Satarker et al.

Summary: As the incidence of COVID-19 increases, efforts are being made to develop therapeutic strategies to combat disease progression, with a focus on the JAK/STAT pathway and its influence on inflammation. Structural and non-structural proteins of SARS-CoV-2 trigger inflammation via this pathway, leading to a cytokine storm in the host. JAK/STAT inhibitors have been employed to reduce excessive inflammation, although their molecular mechanism of action and potential adverse effects require further investigation.

POSTGRADUATE MEDICINE (2021)

Add to Collection

Review Cardiac & Cardiovascular Systems

Pulmonary pathology of ARDS in COVID-19: A pathological review for clinicians

Sabrina Setembre Batah et al.

Summary: COVID-19 caused by SARS-CoV-2 is a global pandemic, with patients progressing from flu-like symptoms to severe acute lung injury characterized by acute and diffuse inflammatory damage to the alveolar-capillary barrier.

RESPIRATORY MEDICINE (2021)

Add to Collection

Review Immunology

Coronavirus disease 2019 (COVID-19): An overview of the immunopathology, serological diagnosis and management

Abubakar Umar Anka et al.

Summary: SARS-CoV-2 infection results in COVID-19, characterized by pneumonia and acute respiratory distress syndrome. The disease triggers inflammatory responses that can cause tissue damage, along with reduced immune cells and cytokine storm in severe cases. Treatment involves antiviral agents and immunomodulators, with varied efficacy, while potential options continue to be explored for combating COVID-19 severity and transmission.

SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2021)

Add to Collection

Review Immunology

T Cells: Warriors of SARS-CoV-2 Infection

Paola de Candia et al.

Summary: Severe infection with SARS-CoV-2 is characterized by massive cytokine release and T cell loss. The exaggerated host immune response, possibly dependent on T cell immunological memory, may significantly contribute to immunopathology and massive collateral damage in COVID-19 patients, especially in adults compared with children.

TRENDS IN IMMUNOLOGY (2021)

Add to Collection

Review Cell Biology

COVID-19: Characteristics and Therapeutics

Rameswari Chilamakuri et al.

Summary: The novel coronavirus (COVID-19) has significantly impacted the world since its emergence at the end of 2019, but there have been major advancements in our understanding of the virus and development of treatment options and vaccines to control the pandemic.

CELLS (2021)

Add to Collection

Article Immunology

Leveraging the antiviral type I interferon system as a first line of defense against SARS-CoV-2 pathogenicity

Daisy A. Hoagland et al.

Summary: This study investigated the systemic response to SARS-CoV-2 infection in hamsters and found that inflammation was present in all tissues but not enough to prevent disease progression. Bolstering the antiviral response with intranasal administration of recombinant IFN-I reduced viral disease, prevented transmission, and lowered inflammation in vivo. This suggests that intranasal IFN-I could be an effective early treatment for SARS-CoV-2 infection.

IMMUNITY (2021)

Add to Collection

Review Immunology

Dual Nature of Type I Interferons in SARS-CoV-2-Induced Inflammation

Cecile King et al.

Summary: Inhibition of IFN-I by SARS-CoV-2 can worsen the disease and affect the immune response, but therapeutic boosting of IFN-I has a narrow time window for efficacy. Further research is needed to explore therapeutic approaches and vaccine design to counteract this limitation.

TRENDS IN IMMUNOLOGY (2021)

Add to Collection

Review Medicine, General & Internal

Severe covid-19 pneumonia: pathogenesis and clinical management

Amy H. Attaway et al.

Summary: Severe covid-19 pneumonia presents challenges for medical research and treatment, with specific risk factors and clinical features identified. Approaches involving high flow nasal cannula, ventilation strategies, and medication choices are important for managing severe cases. Comprehensive interdisciplinary methods are essential for the recovery of critically ill covid-19 patients.

BMJ-BRITISH MEDICAL JOURNAL (2021)

Add to Collection

Article Immunology

Cytokine Signature Induced by SARS-CoV-2 Spike Protein in a Mouse Model

Tingxuan Gu et al.

Summary: This study investigates the mechanism of cytokine storm syndrome (CSS) in COVID-19 and explores potential therapeutic options. TNF-α and IL-6 are suggested to play a role in the occurrence of CSS. The use of certain monoclonal antibodies and inhibitors shows promise in alleviating symptoms of CSS.

FRONTIERS IN IMMUNOLOGY (2021)

Add to Collection

Review Immunology

Commonalities Between ARDS, Pulmonary Fibrosis and COVID-19: The Potential of Autotaxin as a Therapeutic Target

Konstantinos Ntatsoulis et al.

Summary: The study indicates that severe COVID-19 shares similarities with ARDS and ILDs and suggests ATX as a potential common pathologic link and therapeutic target.

FRONTIERS IN IMMUNOLOGY (2021)

Add to Collection

Article Immunology

B Cell Response to Vaccination

Wei Luo et al.

Summary: Vaccines have been crucial in combating infectious diseases by utilizing antibodies produced by effector B cells. Recent research has revolutionized our understanding of B cell response to vaccination, but challenges remain in developing vaccines against various deadly viruses.

IMMUNOLOGICAL INVESTIGATIONS (2021)

Add to Collection

Article Medicine, Research & Experimental

Durable SARS-CoV-2 B cell immunity after mild or severe disease

Clinton O. Ogega et al.

Summary: Research has shown that individuals infected with SARS-CoV-2 develop S-RBD-specific, class-switched rMBCs, regardless of disease severity. This provides evidence for sustained B cell-mediated immunity against the virus.

JOURNAL OF CLINICAL INVESTIGATION (2021)

Add to Collection

Article Multidisciplinary Sciences

The spatial landscape of lung pathology during COVID-19 progression

Andre F. Rendeiro et al.

Summary: Recent studies using high-parameter imaging mass cytometry have provided insights into the cellular composition and spatial architecture of acute lung injury in humans, including injuries derived from SARS-CoV-2 infection. It was found that SARS-CoV-2 predominantly infects alveolar epithelial cells and induces a localized hyperinflammatory cell state associated with lung damage. As COVID-19 progresses, there is increased macrophage extravasation, along with increased numbers of mesenchymal cells and fibroblasts, possibly indicating attempts to repair the damaged lung tissue. The data generated help in developing a biologically interpretable landscape of lung pathology at both macroscopic and single-cell levels, providing a basis for understanding COVID-19 and lung pathology.

NATURE (2021)

Add to Collection

Review Biochemistry & Molecular Biology

Role of SARS-CoV-2 and ACE2 variations in COVID-19

Priya Antony et al.

Summary: COVID-19, caused by SARS-CoV-2, has become one of the worst medical emergencies in almost a century, with the virus mutating and adapting continuously. Variations in ACE2 gene could also impact susceptibility to the virus. A deeper understanding of genetic variations in SARS-CoV-2 and ACE2 is crucial for the development of effective treatments and preventive measures.

BIOMEDICAL JOURNAL (2021)

Add to Collection

Article Medicine, Research & Experimental

Triptolide dose-dependently improves LPS-induced alveolar hypercoagulation and fibrinolysis inhibition through NF-κB inactivation in ARDS mice

Huilin Yang et al.

Summary: In LPS-induced ARDS mice, TP dose-dependently improved alveolar hypercoagulation and fibrinolysis inhibition by inhibiting the NF-kappa B signaling pathway. These effects were similar to those of NBD.

BIOMEDICINE & PHARMACOTHERAPY (2021)

Add to Collection

Review Medicine, General & Internal

The role of vitamin D in the age of COVID-19: A systematic review and meta-analysis

Roya Ghasemian et al.

Summary: This study found that most COVID-19 patients are suffering from vitamin D deficiency/insufficiency. Individuals with vitamin D deficiency have a three times higher risk of getting infected with SARS-CoV-2 and a five times higher probability of developing severe COVID-19 compared to those with sufficient levels of vitamin D. However, there is no significant association between vitamin D deficiency and higher mortality rates in this population.

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2021)

Add to Collection

Article Virology

The NF-κB Transcriptional Footprint Is Essential for SARS-CoV-2 Replication

Benjamin E. Nilsson-Payant et al.

Summary: Research suggests that in SARS-CoV-2 infection, NF-kappa B activation plays a crucial role in viral replication in the absence of traditional IFN-I-related transcription factors. Silencing NF-kappa B transcription factors or using inhibitors can reduce virus replication. These findings contribute to a better understanding of SARS-CoV-2 replication mechanisms and provide a basis for the development of novel treatment approaches.

JOURNAL OF VIROLOGY (2021)

Add to Collection

Review Medicine, General & Internal

Acute respiratory distress syndrome

Nuala J. Meyer et al.

Summary: This article summarizes the epidemiology, diagnosis, and treatment of acute respiratory distress syndrome (ARDS), while also discussing the similarities and differences between ARDS caused by COVID-19 and ARDS caused by other factors.

LANCET (2021)

Add to Collection

Review Biochemistry & Molecular Biology

Mechanistic understanding of innate and adaptive immune responses in SARS-CoV-2 infection

Mumtaz Y. Balkhi

Summary: The SARS-CoV-2 infections have led to a global pandemic affecting human health adversely. The innate and adaptive immune responses triggered by the virus play a crucial role in limiting viral replication and generating optimal immune responses. Research has shown a high level of proinflammatory cytokine release and upregulation of the ACE2 receptor in response to SARS-CoV-2 infection.

MOLECULAR IMMUNOLOGY (2021)

Add to Collection

Article Multidisciplinary Sciences

Activation of NF-κB and induction of proinflammatory cytokine expressions mediated by ORF7a protein of SARS-CoV-2

Chia-Ming Su et al.

Summary: SARS-CoV-2 proteins activate NF-kappa B, leading to the production of proinflammatory cytokines, which may contribute to acute respiratory distress syndrome in COVID-19 patients. Among these proteins, ORF7a plays a significant role in inducing inflammatory cytokines and chemokines expression.

SCIENTIFIC REPORTS (2021)

Add to Collection

Article Public, Environmental & Occupational Health

Prevalence and predictors of in-hospital mortality of patients hospitalized with COVID-19 infection

Faryal Khamis et al.

Summary: The study identified a high mortality rate among COVID-19 patients in a hospital in Oman, with factors such as advanced age, heart disease, liver disease, high ferritin levels, ARDS, sepsis, and ICU admission being associated with mortality.

JOURNAL OF INFECTION AND PUBLIC HEALTH (2021)

Add to Collection

Review Biochemistry & Molecular Biology

Humoral Immunity against SARS-CoV-2 and the Impact on COVID-19 Pathogenesis

Eunjin Lee et al.

Summary: This article introduces key findings on humoral immune responses in COVID-19, including the immune dynamics of antibody responses and correlations with disease severity, neutralizing antibodies and their cross-reactivity, the duration of antibody and memory B-cell responses, aberrant autoreactive antibodies in COVID-19 patients, and the efficacy of currently available therapeutic antibodies and vaccines against circulating SARS-CoV-2 variants, while also highlighting gaps in current knowledge.

MOLECULES AND CELLS (2021)

Add to Collection

Article Biochemistry & Molecular Biology

RNA-induced liquid phase separation of SARS-CoV-2 nucleocapsid protein facilitates NF-κB hyper-activation and inflammation

Yaoxing Wu et al.

Summary: The study reveals that the nucleocapsid (N) protein of SARS-CoV-2 promotes the activation of the NF-κB signaling pathway, leading to inflammatory responses. Inhibiting liquid-liquid phase separation can weaken the regulatory function of this protein, offering a potential therapeutic target for severe pneumonia caused by COVID-19.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)

Add to Collection

Review Medicine, Research & Experimental

Immunopathogenesis and treatment of cytokine storm in COVID-19

Jae Seok Kim et al.

Summary: Severe COVID-19 is characterized by systemic hyper-inflammation and cytokine storm, often leading to acute respiratory distress syndrome and multiple organ failure. Treatment of COVID-19 cytokine storm is crucial, with anti-inflammatory therapies playing a significant role. Various approaches are being used, including new cytokine-targeted therapies, to address the cytokine storm associated with COVID-19.

THERANOSTICS (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals

Alba Grifoni et al.

CELL (2020)

Add to Collection

Editorial Material Immunology

Functional exhaustion of antiviral lymphocytes in COVID-19 patients

Meijuan Zheng et al.

CELLULAR & MOLECULAR IMMUNOLOGY (2020)

Add to Collection

Review Biochemistry & Molecular Biology

Cytokine storm intervention in the early stages of COVID-19 pneumonia

Xinjuan Sun et al.

CYTOKINE & GROWTH FACTOR REVIEWS (2020)

Add to Collection

Review Biochemistry & Molecular Biology

COVID-19: Pathogenesis, cytokine storm and therapeutic potential of interferons

Shivraj Hariram Nile et al.

CYTOKINE & GROWTH FACTOR REVIEWS (2020)

Add to Collection

Review Medicine, General & Internal

The pivotal link between ACE2 deficiency and SARS-CoV-2 infection

Paolo Verdecchia et al.

EUROPEAN JOURNAL OF INTERNAL MEDICINE (2020)

Add to Collection

Article Immunology

Characteristics of Peripheral Lymphocyte Subset Alteration in COVID-19 Pneumonia

Fan Wang et al.

JOURNAL OF INFECTIOUS DISEASES (2020)

Add to Collection

Article Hematology

Increased CD95 (Fas) and PD-1 expression in peripheral blood T lymphocytes in COVID-19 patients

Silvia Bellesi et al.

BRITISH JOURNAL OF HAEMATOLOGY (2020)

Add to Collection

Article Immunology

Acute SARS-CoV-2 Infection Impairs Dendritic Cell and T Cell Responses

Runhong Zhou et al.

IMMUNITY (2020)

Add to Collection

Review Immunology

The COVID-19 Cytokine Storm; What We Know So Far

Dina Ragab et al.

FRONTIERS IN IMMUNOLOGY (2020)

Add to Collection

Editorial Material Medicine, General & Internal

COVID-19 acute respiratory distress syndrome (ARDS): clinical features and differences from typical pre-COVID-19ARDS

Peter G. Gibson et al.

MEDICAL JOURNAL OF AUSTRALIA (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Imbalance of Regulatory and Cytotoxic SARS-CoV-2-Reactive CD4+ T Cells in COVID-19

Benjamin J. Meckiff et al.

CELL (2020)

Add to Collection

Review Biochemistry & Molecular Biology

An aberrant STAT pathway is central to COVID-19

Toshifumi Matsuyama et al.

CELL DEATH AND DIFFERENTIATION (2020)

Add to Collection

Article Pharmacology & Pharmacy

Liu Shen capsule shows antiviral and anti-inflammatory abilities against novel coronavirus SARS-CoV-2 via suppression of NF-κB signaling pathway

Qinhai Ma et al.

PHARMACOLOGICAL RESEARCH (2020)

Add to Collection

Review Pharmacology & Pharmacy

Targeting JAK-STAT Signaling to Control Cytokine Release Syndrome in COVID-19

Wei Luo et al.

TRENDS IN PHARMACOLOGICAL SCIENCES (2020)

Add to Collection

Review Microbiology

Interplay between SARS-CoV-2 and the type I interferon response

Margarida Sa Ribero et al.

PLOS PATHOGENS (2020)

Add to Collection

Article Immunology

Baricitinib, a drug with potential effect to prevent SARS-COV-2 from entering target cells and control cytokine storm induced by COVID-19

Xiuhong Zhang et al.

INTERNATIONAL IMMUNOPHARMACOLOGY (2020)

Add to Collection

Review Biochemistry & Molecular Biology

Natural Killer Cell Dysfunction and Its Role in COVID-19

Charmaine van Eeden et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Add to Collection

Review Biochemistry & Molecular Biology

Vitamin D receptor stimulation to reduce acute respiratory distress syndrome (ARDS) in patients with coronavirus SARS-CoV-2 infections Revised Ms SBMB 2020_166

Jose Manuel Quesada-Gomez et al.

JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2020)

Add to Collection

Article Microbiology

Exploring links between vitamin D deficiency and COVID-19

Mradul Mohan et al.

PLOS PATHOGENS (2020)

Add to Collection

Review Immunology

The Role of Type I Interferons in the Pathogenesis and Treatment of COVID-19

Gideon Schreiber

FRONTIERS IN IMMUNOLOGY (2020)

Add to Collection

Article Immunology

Elevated Exhaustion Levels of NK and CD8+ T Cells as Indicators for Progression and Prognosis of COVID-19 Disease

Mingyue Li et al.

FRONTIERS IN IMMUNOLOGY (2020)

Add to Collection

Article Virology

The novel coronavirus Disease-2019 (COVID-19): Mechanism of action, detection and recent therapeutic strategies

Elahe Seyed Hosseini et al.

VIROLOGY (2020)

Add to Collection

Letter Biochemistry & Molecular Biology

Immune dysfunction leads to mortality and organ injury in patients with COVID-19 in China: insights from ERS-COVID-19 study

Dongze Li et al.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)

Add to Collection

Review Medicine, Research & Experimental

SARS-CoV-2 pandemic and research gaps: Understanding SARS-CoV-2 interaction with the ACE2 receptor and implications for therapy

Prasun K. Datta et al.

THERANOSTICS (2020)

Add to Collection

Article Cell Biology

Nimbolide protects against endotoxin-induced acute respiratory distress syndrome by inhibiting TNF-α mediated NF-κB and HDAC-3 nuclear translocation

Venkatesh Pooladanda et al.

CELL DEATH & DISEASE (2019)

Add to Collection

Article Biochemistry & Molecular Biology

Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK Cells

Pascale Andre et al.

CELL (2018)

Add to Collection

Article Immunology

Type I interferon promotes alveolar epithelial type II cell survival during pulmonary Streptococcus pneumoniae infection and sterile lung injury in mice

Barbara B. Maier et al.

EUROPEAN JOURNAL OF IMMUNOLOGY (2016)

Add to Collection

Review Immunology

Natural Regulators: NK Cells as Modulators of T Cell immunity

Iona S. Schuster et al.

FRONTIERS IN IMMUNOLOGY (2016)

Add to Collection

Review Microbiology

Into the Eye of the Cytokine Storm

Jennifer R. Tisoncik et al.

MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2012)

Add to Collection

Article Clinical Neurology

Fas/FasL-mediated apoptosis and inflammation are key features of acute human spinal cord injury: implications for translational, clinical application

Wen Ru Yu et al.

ACTA NEUROPATHOLOGICA (2011)

Add to Collection

Article Critical Care Medicine

Genetic Variation in the FAS Gene and Associations with Acute Lung Injury

Bradford J. Glavan et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)

Add to Collection

Review Immunology

Functions of natural killer cells

Eric Vivier et al.

NATURE IMMUNOLOGY (2008)

Add to Collection

Article Multidisciplinary Sciences

Angiotensin-converting enzyme 2 protects from severe acute lung failure

Y Imai et al.

NATURE (2005)

Add to Collection

© Peeref 2019-2024. All rights reserved.